NewLink Genetics Corp., an Ames-based biopharmaceutical company at the forefront of developing and commercializing cancer vaccines, announced today that the company will participate in PurpleStride Iowa, a Pancreatic Cancer Action Network (PanCAN) event to promote awareness and raise funds for the fight against pancreatic cancer, the nation’s fourth-leading cause of cancer death. The PurpleStride Iowa PanCAN walk is on Saturday, Sept. 26, at 9:30 a.m. at Raccoon River Park. Pancreatic cancer is expected to become the second-leading cause of cancer-related deaths in the U.S. by 2020. It is one of the deadliest cancers, with a five-year survival rate of just 7 percent. PanCAN raises funds to advance research, support patients and create hope for the pancreatic cancer community. To join the NewLink Genetics team, or make a donation, please visit the NewLink Genetics team page. To learn more about the Pancreatic Cancer Action Network and how you can make a difference,click here.